Life science research and healthcare are a nationwide conversation. The White House is using major initiatives to push innovation in precision medicine and cancer. Zika virus has spread to our shores. Drug prices are a hot-button topic for presidential candidates, activist patients, and everybody in between.
Xconomy wants to talk about it all. Join National Biotechnology Editor Alex Lash in San Francisco on December 6 for a post-election exploration of the biggest health and biotechnology issues across the land. Topics will include the future of national health initiatives, the intersection of Big Data and healthcare, the looming presence of genetic modification, and our national response to infectious disease.
Confirmed Speakers:
John Wilbanks, Chief Commons Officer, Sage Bionetworks
Vijay Pande, General Partner, Andreessen Horowitz
Peter Kuhn, Dean’s Professor of Biological Sciences; Professor of Medicine and Engineering, USC
Jacob Corn,, Scientific Director, Innovative Genomics Initiative, UC Berkeley
Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology, UCSF
Marcy Darnovsky, Executive Director, Center for Genomics and Society
Camille Samuels, Partner, Venrock
Duncan MacCannell, CSO, OAMD, Centers for Disease Control and Prevention
Matthew Porteus, Associate Professor of Pediatrics (Stem Cell Transplantation), Stanford University
Nima Farzan, CEO, PaxVax
Jenny Rooke, Managing Director 5, Prime Ventures
Laurent Fischer, CEO, Tobira Therapeutics
Aarif Khakoo, VP Research and San Francisco Site Head, Amgen
Adams Dudley, Director, UCSF Center for Healthcare Value
Follow us on Twitter:
@Xconomy
#xconbio
Schedule:
Registration: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
